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OBJECTIVE—Hyperglycemia-associated microvascular disease
may underlie changes in cerebral functioning and cognitive
performance in patients with type 1 diabetes. Functional connec-
tivity, an indicator of functional interactions and information
exchange between brain regions, provides a measure of cerebral
functioning. This study addresses functional connectivity and
cognition in type 1 diabetic patients with and without prolifera-
tive retinopathy, relative to healthy control subjects, using
magnetoencephalography.
RESEARCH DESIGN AND METHODS—Fluctuations in mag-
netic ﬁeld at scalp for , , lower and upper , , and lower and
upper  frequency bands were measured using magnetoencepha-
lography. Synchronization likelihood, a measure of functional
connectivity, was computed. Using neuropsychological tests,
cognitive functioning was assessed and its associations with
functional connectivity were determined.
RESULTS—Compared with control subjects, type 1 diabetic
patients performed poorer on general cognitive ability, informa-
tion processing speed, and motor speed, irrespective of their
microvascular complication status. Functional connectivity,
however, was lowest for type 1 diabetic patients with retinopa-
thy, compared with type 1 diabetic patients without microvascu-
lar complications and control subjects, whereas type 1 diabetic
patients without microvascular complications showed an in-
crease relative to control subjects. Positive associations were
found between functional connectivity and executive function-
ing, memory, information processing speed, motor speed, and
attention.
CONCLUSIONS—Compared with healthy control subjects,
functional connectivity and cognition differed in type 1 diabetic
patients irrespective of microvascular complication status, indi-
cating that chronic hyperglycemia, among other factors, may
negatively affect brain functioning even before microvascular
damage becomes manifest. The association found between syn-
chronization likelihood and cognition suggests functional con-
nectivity plays a signiﬁcant role in cognitive functioning.
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M
ild cognitive deterioration and changes in
cerebral anatomy have been demonstrated in
patients with long-standing type 1 diabetes.
These cognitive disturbances are limited to
slowed information processing speed, attentional func-
tioning, and primary motor as well as psychomotor speed
(1–3). Using structural magnetic resonance imaging (MRI),
reductions in cerebral gray and white matter volume in
type 1 diabetes compared with healthy control subjects
were reported (4–6). To measure important functional
changes, electroencephalography can be used. In children
with type 1 diabetes, increases in slow ( and ) activity,
decreases in fast (, , and  frequency bands) activity,
and a reduction in  peak frequency were found. These
functional cerebral changes were correlated with both
poor glycemic control and more episodes of severe hypo-
glycemia (7). Compared with healthy control subjects,
there was a loss of fast activity in well-controlled diabetic
adults (8). These changes were unrelated to a history of
severe hypoglycemic events. Although the underlying neu-
ropathological and biological substrates are undeﬁned,
there is evidence that chronic hyperglycemia, leading to
microangiopathy in the brain, may be the main cause of
these cerebral complications (3,5,6,9).
A relatively novel and more advanced approach to
measuring brain activity is magnetoencephalography
(MEG). MEG measures ﬂuctuations of magnetic ﬁelds of
the brain at the scalp. MEG has been widely used in the
study of functional changes associated with neurological
disorders including Alzheimer’s disease (10), Parkinson’s
disease (11), brain tumors (12), and metabolic disorders
such as obesity (13,14) and hepatic encephalopathy (15).
With MEG data, functional connectivity can be calcu-
lated. This refers to the assumption that correlations
between time series of neural activity recorded from
different brain regions reﬂect functional interactions and
information exchange between these regions (16,17). Dif-
ferences in functional connectivity indicate a different way
of communication between brain areas. Functional con-
nectivity has been thought to be a core component of
cognitive functioning, as most cognitive functions highly
depend on interactions between distinct cerebral regions
rather than on single brain regions or structures. There-
From the
1Department of Medical Psychology and Endocrinology, VU Univer-
sity Medical Center, Amsterdam, the Netherlands; the
2Department of
Medical Psychology, VU University Medical Center, Amsterdam, the Neth-
erlands; the
3Department of Clinical Neurophysiology and MEG Center, VU
University Medical Center, Amsterdam, the Netherlands; the
4Department
of Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands; the
5Department of Ophthalmology, VU University Medical Center, Amsterdam,
the Netherlands; and the
6Department of Endocrinology and Diabetes
Center, VU University Medical Center, Amsterdam, the Netherlands.
Corresponding author: Eelco van Duinkerken, e.vanduinkerken@vumc.nl.
Received 20 March 2009 and accepted 24 June 2009.
Published ahead of print at http://diabetes.diabetesjournals.org on 7 July 2009.
DOI: 10.2337/db09-0425.
© 2009 by the American Diabetes Association. Readers may use this article as
long as the work is properly cited, the use is educational and not for proﬁt,
and the work is not altered. See http://creativecommons.org/licenses/by
-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
ORIGINAL ARTICLE
diabetes.diabetesjournals.org DIABETES, VOL. 58, OCTOBER 2009 2335fore, functional connectivity may, at least in part, explain
cognitive functioning, and changes in functional connec-
tivity might account for cognitive deterioration (18).
In this study, MEG functional connectivity relative to
healthy control subjects was investigated in a group of
type 1 diabetic patients with proliferative retinopathy as a
marker of hyperglycemia and a group of type 1 diabetic
patients without microvascular complications. Further-
more, neurocognitive functioning and its association with
functional connectivity was assessed. Based on earlier
studies (9,19) we expected type 1 diabetic patients with
proliferative retinopathy to show cognitive deterioration
and lower functional connectivity compared with healthy
control subjects and type 1 diabetic patients without
microvascular complications.
RESEARCH DESIGN AND METHODS
Fifteen type 1 diabetic patients with proliferative retinopathy, an indicator of
microangiopathy resulting from chronic hyperglycemia (type 1 diabetes
), 29
type 1 diabetic patients without manifest microvascular complications (type 1
diabetes
), and 26 healthy control subjects matched for sex and education
level enrolled in this study. Participants were recruited from the departments
of Endocrinology and Ophthalmology of the VU University Medical Center,
Amsterdam, the Netherlands (50 patients), the department of Internal Medi-
cine, Groene Hart Hospital, Gouda, the Netherlands (10 patients), and by
advertisements in diabetes magazines and a national newspaper (10 patients).
Inclusion criteria were age range 18–55 years, right-handedness, for type 1
diabetic patients a disease duration of at least 10 years, proliferative retinop-
athy as described below, or no signs of microvascular complications. Mastery
of the Dutch language was required for all participants. Participants were
excluded if they had a BMI above 35 kg/m
2, current use of drugs affecting
cerebral functioning, alcohol abuse (more than 20 g of alcohol per day),
psychiatric disorders, anemia, thyroid dysfunction, use of glucocorticoids,
hepatitis, stroke, severe head trauma, epilepsy, pregnancy, or poor visual
acuity below 0.3. Fundus photography (Topcon NW 100, Capelle aan den
IJssel, the Netherlands) was performed to screen for retinopathy. For each
eye, one photograph with the macula in the center and one with the optic disc
in the center were taken (E.v.D.). Photographs were rated by an ophthalmol-
ogist (A.M.) according to the European Diabetes (EURODIAB) classiﬁcation
(20). Only those participants with either an EURODIAB classiﬁcation score
of 0 (no retinopathy) or of 4 or 5 (proliferative retinopathy or lasercoagu-
lation) were included in this study. Twenty-four–hour urine collections
were performed to assess albumin-to-creatinine ratio (ACR). The presence
of peripheral neuropathy was ascertained by the physician. Type 1
diabetes
 patients had normoalbuminuria (ACR 2.5 mg/mmol in men and
3.5 mg/mmol in women) and no neuropathy. Type 1 diabetes
 patients
were allowed to have microalbuminuria and/or peripheral neuropathy.
Hypertension was deﬁned as a systolic blood pressure of 140 mmHg or
above, a diastolic blood pressure of 90 mmHg or above, or the use of
antihypertensive drugs. The study protocol was approved by the Medical
Ethics Committee of the VU University Medical Center, and written
informed consent was obtained from all participants.
Study design. Before eligible participants received written information on
the study, their medical records were screened using the aforementioned
criteria. Those willing to participate were additionally interviewed over the
telephone to collect background information including educational level,
using a Dutch scoring system ranging from 1 to 8. One indicates unﬁnished
primary school and 8 indicates a completed university study at masters level.
As depression may affect cognitive performance, depressive symptoms were
assessed using the Center for Epidemiological Studies scale for Depression
(CES-D). Eligible participants were invited for the ﬁrst visit. During this visit,
which took place in the afternoon, fundus photography was performed, blood
samples were collected, and MEG registration was performed. Approximately
6 weeks after the ﬁrst visit participants returned for neuropsychological
assessment during a morning visit. All visits took place at the VU University
Medical Center.
To rule out confounding as a result of extreme blood glucose levels, levels
were checked in the type 1 diabetes participants before the start of the
neuropsychological assessment and MEG registration and had to be between
4 and 15 mmol/l (72–270 mg/dl). In case of hypoglycemia, participants were
instructed to eat 20 g of carbohydrates. In case of hyperglycemia, patients
were instructed to inject 2 units of the participants’ current rapid-acting
insulin analog when blood glucose levels were between 15 and 20 mmol/l
(270–362 mg/dl) and 4 units when glucose levels exceeded 20 mmol/l (362
mg/dl). Glycemic status was evaluated after 30 min. If hyperglycemia (i.e.,
blood glucose 15 mmol/l) would persist, participants were instructed to
inject another 2 units of insulin; if hypoglycemia would persist, participants
additionally had to eat 20 g of carbohydrates. Two type 1 diabetes
 partici-
pants were hyperglycemic before start of the neuropsychological assessment
and one before MEG acquisition. One type 1 diabetes
 patient indicated
symptoms of hypoglycemia during neuropsychological testing. Proper glyce-
mic status was restored for all patients after the ﬁrst step of the above-
mentioned protocol. Data of the one participant who experienced
hypoglycemia symptoms during neuropsychological testing were included in
all analyses, as this did not change analysis outcomes.
Neuropsychological assessment. Based on earlier type 1 diabetes cognitive
research (5,21), as well as clinical neuropsychological practice (22), a battery
of cognitive tests was chosen to measure potential differences in ﬁve major
cognitive domains: memory, information processing speed, executive func-
tions, attention, and motor speed. Domains were based on an earlier principal
component analysis using varimax rotation with Kaiser normalization in a
large group of healthy subjects and adjusted according to earlier research
(5,21,23).
The domain ‘memory’ was assessed by the Dutch version of the Rey
Auditory Verbal Learning Test (RALVT) (24), Wechsler Adult Intelligence
Scale–3rd edition revised (WAIS-III-R) Digit Span forward and backward (25),
and the WAIS-III-R Symbol Substitution Incidental Learning Test (25). The
domain ‘information processing speed’ was created using the WAIS-III-R
Symbol Substitution Test (25), the Stroop Color-Word Test parts 1 and 2 (26),
the Concept Shifting Task (CST) parts A and B (27), the Simple Auditory and
Visual Reaction Time Tests (28), and the Computerized Visual Searching Task
(CVST) (28). Assessment of the domain ‘executive functions’ was conducted
using the Stroop Color-Word Test part 3 (26), the CST part C (27), the D2-test
total errors (29), the Wisconsin Cart Sorting Test (30), and the Category Word
Fluency Task (31). The domain ‘attention’ was assessed using the D2-test
range, with total correct answers and total span (29). The domain ‘motor
speed’ consisted of the Tapping Test (28) and the CST part 0, administered
three times (27). ‘General cognitive ability’ was constructed by averaging the
above mentioned ﬁve domains.
To enhance comparability and allow construction of these domains,
z-scores for every test were created based on the means 	 SD of the healthy
control group. Higher z-scores indicate better performance.
MEG protocol. MEG data were obtained using a 151-channel whole-head
MEG system (CTF systems; Port Coquitlam, BC, Canada), while participants
were in a supine position in a magnetically shielded room (Vacuumschmelze,
Hanau, Germany). A third-order software gradient (32) was used with a
recording passband of 0.25–125 Hz and a sample frequency of 625 Hz.
Participants had to be free of any metal materials. Magnetic ﬁelds were
recorded for 2 min in an eyes-open, 5 min in an eyes-closed, 10 min in a task,
and then 3 min in another eyes-closed condition. Total acquisition time was 20
min. At the beginning, middle, and end of each recording, the head position
relative to the coordinate system of the helmet was determined by leading
small alternating currents through three head position coils attached to the
left and right preauricular points and the nasion on the subjects head. Changes
in head position of 
1.5 cm during a recording condition were accepted. If
head position changed more than 1.5 cm, recordings had to be repeated. This
did not happen in this protocol.
Synchronization likelihood. From the acquired MEG data, information
about functional connectivity was calculated by means of a mathematical
construct, the synchronization likelihood. For a technical description of
synchronization likelihood see Stam and van Dijk (33) and Montez et al. (34).
In short, interactions between two neural networks, for instance the frontal
(X) and temporal (Y) networks, are of interest. MEG data are recorded for all
sensors surrounding the head, including those in the frontal and temporal
areas. These signals represent the time series xi and yi from the frontal (X) and
temporal (Y) areas (Fig. 1). It is assumed that X and Y more strongly interact
when xi and yi more ‘resemble’ each other (square with continuous line in Fig.
1). It has been shown, however, that X and Y can also interact when xi and yi
do not resemble each other (square with the dashed line in Fig. 1). This is
called generalized synchronization and can be quantiﬁed by computing
synchronization likelihood. Parameter settings used for computation of syn-
chronization likelihood are based on the frequency content of the data (for
parameter settings see Montez et al. [34]). Synchronization likelihood can
range from Pref (low synchronization) to one (complete synchronization). Pref
is a value close to zero (zero indicates no synchronization, which is not
possible) and was set on 0.01 for all frequency bands.
Data analysis. For this analysis, 141 of the 151 channels were used. Ten
channels were deleted as their signals were distorted in some participants.
This had no inﬂuence on the calculations. Ofﬂine, recordings of the ﬁrst
eyes-closed condition were transformed into ASCII-ﬁles and imported into the
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the Netherlands). For each participant ﬁve artifact-free epochs (6.25 s) of
4,096 samples were selected by two authors (E.v.D. and N.S.). Total data used
were 31.25 s. With DIGEEGXP synchronization likelihood was calculated (33).
Synchronization likelihood was calculated between signals recorded at all
possible sensor pairs for  (0.5–4 Hz),  (4–8 Hz), lower  (8–10 Hz), upper
 (10–13 Hz),  (13–30 Hz), lower  (30–45 Hz), and upper  (55–80 Hz)
frequency bands. Subsequently, MEG sensors were clustered according to
their anatomical location, respectively, right and left frontal, central,
parietal, temporal, and occipital. Average synchronization likelihood val-
ues were then obtained for short-distance, intrahemispheric long-distance,
and interhemispheric long-distance groups. Short-distance group consisted
of 10 areas, left and right hemisphere central, frontal, parietal, occipital,
and temporal regions. For each of these 10 areas, the synchronization
likelihood between all possible pairs of sensors belonging to that area was
averaged. This resulted in ten, local short-distance synchronization likeli-
hood values. Average synchronization likelihood for long distances was
obtained by averaging all pair wise synchronization likelihood values of
sensors belonging to two different areas. Intrahemispheric long-distance
group consisted of eight pairs, left and right hemisphere frontoparietal,
frontotemporal, parietoocciptal, and temporooccipital. Interhemispheric
long-distance group consisted of ﬁve pairs, left to right hemisphere central,
parietal, temporal, occipital, and frontal (12,13). See Fig. 2 for anatomical
locations. Now, synchronization likelihood resembles the likelihood that
the data obtained from all sensors in the above-deﬁned short-distance and
long-distance groups are synchronized.
FIG. 1. Example of time series of the frontal and temporal network. The square with the continuous line indicates a time series showing high
resemblance between both networks. The square with the dashed line is an example of a time series showing low resemblance. A: Network X
(frontal). B: Network Y (temporal).
FIG. 2. Schematic brain, with left and right frontal (LF and RF, respectively), central (LC and RC, respectively), parietal (RP and LP,
respectively), occipital (LO and RO, respectively), and temporal (LT and RT, respectively) areas indicated as abbreviations. A and B:
Long-distance intrahemispheric pathways. Eight long-distance intrahemispheric pathways (A) and ﬁve long-distance interhemispheric pathways
(B). C: Ten short-distance local hemispheric pathways.
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medical variables were calculated using Student’s t test for independent
samples or one-way ANOVA with Tukey post hoc test (for continuous
variables) and 
2 test (for categorical variables).
To determine group differences in neuropsychological performance MAN-
COVA was used with all cognitive domains as dependent variables and group
as independent variable. In case of a group difference on a domain, post hoc
MANCOVA was used to determine which groups differed.
Synchronization likelihood data were normalized by means of a transfor-
mation LN10(x/[1-x]) (35) to allow the use of parametric statistical tests. To
minimize statistical tests, for each MEG frequency band ANCOVA with
repeated measures was used to determine group differences. For each
frequency band, three ANCOVAs with repeated measures were performed for
intra-, inter-, and local hemispheric connections. Repeated measures for
intrahemispheric connections consisted of the 8 above-mentioned levels,
interhemispheric connections of 5 levels, and local hemispheric connections
of 10 levels. In case of signiﬁcant interaction (P values of Greenhouse-Geisser
correction for degrees of freedom) or main effects of group with frequency
band, post hoc MANCOVA analysis was used to determine effects of group and
spatial location. To determine associations between cognitive functioning and
synchronization likelihood, a procedure proposed by Stoffers et al. and used
in other MEG research was implemented (11,12). To reduce multiple compar-
isons, cognitive domains were added as covariates to the above-mentioned
ANCOVA with repeated measures method. Effects of group on changing
cognitive domains and MEG regions were determined using MANCOVA tests.
Positive or negative associations were further calculated using regression
analysis. To correct for possible confounding inﬂuences, all statistical tests
were corrected for age, sex, hypertension, neuropathy, BMI, education level,
and depressive symptoms.
Partial 
2 is reported as a proportion of the total variance explained of the
determinant by the independent factor corrected for the used covariates. All
statistical analyses were performed using SPSS for Windows version 15.0
(SPSS, Chicago, IL).
RESULTS
Patient characteristics. Table 1 summarizes group char-
acteristics. The control group was signiﬁcantly younger
than the type 1 diabetes
 patients and had a signiﬁcantly
lower mean score of depressive symptoms. As expected,
type 1 diabetes participants had a higher A1C than control
subjects. Type 1 diabetes
 patients had a signiﬁcantly
lower age of disease onset and longer disease duration.
Neuropsychological assessment. Compared with con-
trol subjects, both patient groups had a signiﬁcantly lower
information processing speed (type 1 diabetes
: P 
 0.003,

2 
 0.242; type 1 diabetes
: P 
 0.009, 
2 
 0.135) and
motor speed (type 1 diabetes
: P  0.001, 
2 
 0.311; type
1 diabetes
: P 
 0.014, 
2 
 0.122) as well as general
cognitive ability (type 1 diabetes
: P 
 0.007, 
2 
 0.198;
type 1 diabetes
: P 
 0.004, 
2 
 0.165). There were no
statistically signiﬁcant differences between the patient
groups. The z scores are displayed in Fig. 3.
MEG measurements. MEG results are shown in Table 2
(with P values and 
2) and visually represented in Fig. 4.
First, repeated-measures ANCOVA was performed for all
frequency bands. Signiﬁcant interaction effects with group
were found for the  band local (P 
 0.001), lower  band
local (P 
 0.004), upper  band local (P 
 0.008),  band
interhemispheric (P 
 0.043), and  band local (P 

0.020). Signiﬁcant main effects of group were found for the
lower  band intrahemispheric (P 
 0.028), lower  band
local hemispheric (P 
 0.005), and upper  band local
(P 
 0.042). Post hoc MANCOVA analysis revealed signif-
icantly higher synchronization likelihood in the lower 
right parietooccipital pathway for the type 1 diabetes

compared with the healthy control subjects. Comparing
type 1 diabetes
 patients with control subjects revealed
signiﬁcantly lower synchronization likelihood in the  and
lower  left and right central and parietal areas, in the
upper  left frontal and right frontal, central, and parietal
areas, and in the  interparietal, left parietal and right
central, and parietal areas. Comparisons of type 1 diabe-
tes
 with type 1 diabetes
 patients yielded lower synchro-
TABLE 1
Patient characteristics
Type 1 diabetes

patients (n 
 15)
Type 1 diabetes

patients (n 
 29)
Control subjects
(n 
 26) P
Age (years) 44.2 	 6.74 39.0 	 8.76 36.7 	 10.5 0.046
Sex (men/women) 6/9 16/13 16/10 0.950
Education level* 5.5 	 2.1 5.7 	 1.85 5.6 	 1.45 0.953
Estimated IQ† 110.7 	 10.44 105.3 	 12.57 107.4 	 11.67 0.366
A1C 7.7 	 0.81 7.8 	 0.91 5.4 	 0.24 0.001
Depressive symptoms‡ 11.3 	 9.04 7.5 	 6.46 5.4 	 0.96 0.027
Risk of major depression§ (%) 3 (20) 2 (7) 1 (4) 0.203
BMI (kg/m
2) 25.6 	 5.89 24.8 	 3.27 25.2 	 3.95 0.853
Hypertension (%) 10 (67) 9 (31) — 0.030
Type 1 diabetes onset age (years) 9.7 	 4.62 19.2 	 10.03 — 0.001
Type 1 diabetes disease duration (years) 34.5 	 6.75 19.8 	 8.86 — 0.001
Type 1 diabetes early onset¶ (%) 3 (20) 3 (10) — 0.394
Severe hypoglycemic events** 7.0 	 7.76 4.8 	 10.73 — 0.478
Blood glucose level before MEG (mmol/l) 9.9 	 3.81 9.0 	 4.74 — 0.549
Blood glucose level before NPA†† (mmol/l) 9.7 	 4.41 9.0 	 4.23 — 0.656
Daily insulin units injected (units per day) 50.3 	 20.12 56.3 	 20.01 — 0.361
Neuropathy‡‡ (%) 8 (53) — — —
Nephropathy§§ (%) 2 (13) — — —
Values are means 	 SD or absolute numbers (%). *Education level measured with a Dutch scoring system from 1 to 8, with 1 representing
unﬁnished primary school and 8 representing university at masters level. †Measured with the Dutch version of the National Adult Reading
Test. ‡Depressive symptoms measured using the CES-D. §Risk of major depression was deﬁned as a CES-D score of 16 or above.
Hypertension was deﬁned as a systolic blood pressure of 140 mmHg or above, a diastolic blood pressure of 90 mmHg or above, or use of
antihypertensive drugs. ¶Early disease onset is deﬁned as onset below 7 years of age. **Averaged amount of self-reported severe
hypoglycemic events per individual. Severe hypoglycemic events are those events for which the participants need others’ assistance to cope
with the effects of low blood glucose, loss of consciousness, or seizure. ††Neuropsychological assessment. ‡‡Neuropathy was based on
physicians report. §§Nephropathy was based on a 24-h urine sample and deﬁned as an ACR of 2.5 or above for men and 3.5 for women.
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 patients in
the  left and right central and parietal areas, in the lower
 band left frontotemporal, left parietooccipital, right
parietooccipital, and right temporooccipital pathways, in
the left frontal and left and right central and parietal areas,
upper  left parietal and right central and parietal areas
and in the -right parietal area. Anatomical locations are
illustrated in Fig. 2.
To summarize, type 1 diabetes
 patients showed lower
synchronization likelihood in both higher and lower fre-
quency bands compared with both type 1 diabetes
 pa-
tients and control subjects. Type 1 diabetes
 patients
showed increased synchronization likelihood in the lower
 band compared with control subjects. No statistically
signiﬁcant differences were found when the combined pa-
tient groups were compared with healthy control subjects.
On the contrary, a signiﬁcant difference in the  intrahemi-
spheric region was observed (supplementary Table 1A
and B, available in an online appendix at http://diabetes.
diabetesjournals.org/cgi/content/full/db09-0425/DC1).
Correlation between MEG and cognitive perfor-
mance. To test for associations between functional con-
nectivity in different MEG frequency bands and cognition,
MEG statistics were repeated with cognitive domains
added as additional covariates for both type 1 diabetes
groups. In type 1 diabetes
 patients signiﬁcant associations
were found between the domain of executive functions and
 intrahemispheric (P 
 0.041),  interhemispheric (P 

0.008), and  local (P 
 0.043) frequency band. Further-
more,  interhemispheric was related to the domains of
memory (P 
 0.030), information processing speed (P 

0.040), and motor speed (P 
 0.014). The lower  local
frequency band was related to attention (P 
 0.047). For
executive functions only, signiﬁcant relations with ana-
tomical areas were found. In the type 1 diabetes
 patients
signiﬁcant relations were found between attention and 
intrahemispheric (P 
 0.048), upper  intrahemispheric
(P 
 0.013), and interhemispheric (P 
 0.043). Motor
speed was associated with  local (P 
 0.028) and  local
(P 
 0.036). Lastly,  intrahemispheric was associated
with information processing speed (P 
 0.040). Subse-
quently, regression analysis was used to determine posi-
tive or negative relations between synchronization
likelihood and cognition. In both groups, an increase in
synchronization likelihood was associated with better
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FIG. 3. Bar chart of all cognitive domains. The x-axis represents healthy control subjects. Black bars indicate type 1 diabetes
 and white bars
indicate type 1 diabetes
 patients. Z values were created based on the means  SD of the healthy control subjects. Asterisk indicates signiﬁcant
decline for type 1 diabetes
 and type 1 diabetes
 patients compared with healthy control subjects.
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MANCOVA and regression tests.
DISCUSSION
This is, to the best of our knowledge, the ﬁrst study using
MEG to assess functional brain connectivity in type 1
diabetes. We showed that, compared with sex- and educa-
tion-matched type 1 diabetes
 patients and control sub-
jects, type 1 diabetes
 had decreased functional
connectivity. This decrease was most profound in the left
and right central and parietal areas in the , lower and
upper , and  frequency bands. Moreover, some intra-
and interhemispheric differences were found in the lower
 and  bands. In contrast, an increase in functional
connectivity was found in the lower  band when compar-
ing the type 1 diabetes
 patients with control subjects.
Several frequency bands were positively related to cogni-
tive domains, indicating these domains to be dependent of
functional connectivity. On cognitive assessment, type 1
diabetic patients with and those without proliferative
retinopathy performed signiﬁcantly poorer on information
processing speed, motor speed, and general cognitive
ability. These deﬁcits are in line with previous research
(1,3,36). Results are in line with the hypothesis that type 1
diabetes
 patients show cognitive and cerebral changes.
Changes found in type 1 diabetes
 patients were, however,
not hypothesized. When both patient groups were pooled
and compared with control subjects, cognitive results did
not change; however, all differences in MEG measure-
ments, but those in the  intrahemispheric band, lost
statistical signiﬁcance (supplementary Table 1A and B,
available in an online appendix). This indicates that type 1
diabetes
 patients largely resemble the control subjects
regarding functional connectivity.
Given the novelty of the technique used, caution is
required when it comes to the interpretation of our con-
nectivity ﬁndings. As there is currently only one study
available that uses our method in metabolic disease, it may
be difﬁcult to put the current ﬁndings into a broader
perspective. In female obese adolescents, signiﬁcant in-
creases in functional connectivity in  and  frequency
bands were found (13), possibly because of an increase in
TABLE 2
Raw synchronization likelihood values for signiﬁcant group differences
Type 1 diabetes

patients (n 
 15)
Type 1 diabetes

patients (n 
 29)
Control subjects
(n 
 26) P 
2
 band (4–8 Hz)
Left central 0.100 	 0.016 0.113 	 0.013 0.010 0.171
0.100 	 0.016 0.114 	 0.017 0.003 0.237
Left parietal 0.182 	 0.026 0.215 	 0.034 0.008 0.182
0.182 	 0.026 0.214 	 0.032 0.001 0.270
Right central 0.088 	 0.009 0.100 	 0.013 0.014 0.158
0.088 	 0.009 0.105 	 0.018 0.003 0.243
Right parietal 0.147 	 0.018 0.167 	 0.022 0.015 0.153
0.147 	 0.018 0.169 	 0.025 0.001 0.273
Lower  band (8–10 Hz)
Left frontotemporal 0.031 	 0.008 0.033 	 0.010 0.042 0.110
Left parietooccipital 0.041 	 0.010 0.047 	 0.013 0.018 0.147
Left frontal 0.109 	 0.026 0.118 	 0.020 0.039 0.113
Left central 0.104 	 0.019 0.124 	 0.023 0.001 0.249
0.104 	 0.019 0.118 	 0.020 0.027 0.140
Left parietal 0.192 	 0.040 0.234 	 0.045 0.226 	 0.040 0.003 0.218
0.192 	 0.040 0.031 0.133
Right parietooccipital 0.037 	 0.006 0.048 	 0.018 0.004 0.209
0.048 	 0.018 0.040 	 0.018 0.034 0.093
Right temporooccipital 0.028 	 0.007 0.029 	 0.005 0.050 0.102
Right central 0.091 	 0.013 0.108 	 0.018 0.005 0.196
0.091 	 0.013 0.109 	 0.019 0.005 0.211
Right parietal 0.152 	 0.026 0.187 	 0.036 0.002 0.230
0.152 	 0.026 0.180 	 0.033 0.005 0.212
Upper  band (10–13 Hz)
Left frontal 0.100 	 0.164 0.112 	 0.025 0.034 0.129
Left parietal 0.192 	 0.048 0.218 	 0.038 0.038 0.114
Right frontal 0.117 	 0.017 0.133 	 0.020 0.011 0.179
Right central 0.089 	 0.012 0.099 	 0.013 0.035 0.118
0.089 	 0.012 0.102 	 0.016 0.023 0.179
Right parietal 0.153 	 0.027 0.177 	 0.026 0.012 0.162
0.153 	 0.027 0.176 	 0.020 0.004 0.227
 band (13–30 Hz)
Interparietal 0.031 	 0.012 0.036 	 0.009 0.025 0.025
Left parietal 0.174 	 0.034 0.199 	 0.030 0.027 0.139
Right central 0.082 	 0.011 0.090 	 0.011 0.016 0.165
Right parietal 0.142 	 0.025 0.157 	 0.024 0.043 0.109
0.142 	 0.025 0.158 	 0.021 0.016 0.163
Data are given as mean synchronization likelihood values per group 	 SD. P value and 
2 (percentage of total variance explained by
the determinant) are given.
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obese adolescents. This is contrary to the decrease we
found in our group. In contrast, in multiple sclerosis a
decrease in functional connectivity was reported (37).
This might be related to a loss of white matter, one of the
core features of the disease. Following this line of reason-
ing, our results for the type 1 diabetes
 patients could be
a consequence of white matter loss, as has been found
earlier in type 1 diabetes
 patients than type 1 diabetes

patients and healthy control subjects (5). Conversely, the
increase in functional connectivity in type 1 diabetes

patients might reﬂect a compensatory mechanism, which
fails in type 1 diabetes
 patients. Because of large inter-
individual differences in cognitive performance, this com-
pensation was not observed in cognitive functioning.
Therefore, larger samples are needed to enable the detec-
FIG. 4. Schematic brain with between-group differences in synchronization likelihood per frequency band. Black and gray indicate lower
synchronization likelihood; black dashed arrows indicate higher synchronization likelihood. Gray circles indicate lower short-distance local
hemispheric differences with P < 0.05; black circles indicate lower short-distance local hemispheric differences with P < 0.01; gray arrows
indicate either lower long-distance intra- or interhemispheric differences with P < 0.05; black arrows indicate either lower long-distance intra-
or interhemispheric differences with P < 0.01; black dashed arrow indicates higher long-distance intrahemispheric differences with P < 0.05.
T1DM, type 1 diabetes.
TABLE 3
Associations between cognition and MEG frequency bands for type 1 diabetes
 and type 1 diabetes
 patients
Frequency band Cognitive domain P 
2 
Type 1 diabetes


Right frontotemporal Executive functions 0.039 0.478 0.205
Right temporooccipital Executive functions 0.048 0.450 0.384
Inter frontal Executive functions 0.037 0.486 0.421
Right frontal Executive functions 0.029 0.559 0.498
Right occipital Executive functions 0.034 0.498 0.550
Right temporal Executive functions 0.020 0.560 0.453
Type 1 diabetes


Left central Motor speed 0.001 0.502 0.662
Left parietal Motor speed 0.005 0.338 0.517

Left central Motor speed 0.001 0.413 0.596
Left frontal Motor speed 0.001 0.502 0.736
Left parietal Motor speed 0.038 0.198 0.391
Right parietal Motor speed 0.030 0.215 0.414

Left frontotemporal Information processing speed 0.016 0.257 0.504
Upper 
Right frontotemoporal Attention 0.036 0.202 0.398
Right parietooccipital Attention 0.034 0.205 0.412
Right temporooccipital Attention 0.048 0.182 0.393
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
and type 1 diabetes
 patients.
Importantly, we found a signiﬁcant positive relationship
between cognitive functioning and functional connectiv-
ity, suggesting changes in functional connectivity are
involved in cognitive dysfunction in type 1 diabetic
patients.
Our data support the hypothesis that cerebral changes
are related to the presence of microvascular complica-
tions. However, we also found indications that cerebral
and cognitive changes may be present before microvascu-
lar complications become apparent. It could be hypothe-
sized that chronic hyperglycemia, even in the absence of
clinically detectable microvascular complications, can
negatively affect cognitive functioning and cerebral com-
munication. It is known that hyperglycemia as such leads
to a cascade of changes, including increases in formation
of reactive oxygen species and advanced glycation end
products (38,39), as well as activation of the hypothalamic-
pituitary-adrenal axis (40), which could have an effect on
the brain. Effects of hypoglycemia, particularly of asymp-
tomatic hypoglycemic episodes because of hypoglycemia
unawareness, cannot be completely ruled out as a contrib-
utor. Subsequently, we corrected for severe hypoglycemic
events. This did not change the results (supplementary
Table 2A–C, available in an online appendix).
Another possible contributor to the altered functional
connectivity and cognitive functions observed in type 1
diabetic patients may be cerebrovascular, that is, macro-
vascular disease, the subclinical form of which can be
estimated by ultrasound measurements of the carotid
intima media thickness, which is known to be increased in
asymptomatic type 1 diabetic patients relative to their
nondiabetic peers (41). Furthermore, early diabetes onset,
deﬁned as disease onset before 7 years of age, has been
shown previously to negatively affect intellectual and
cognitive performance and cerebral structure (42,43).
Some limitations of this study should be mentioned.
First, MEG provides a high temporal resolution. Unfortu-
nately, the spatial resolution is lower. For a higher spatial
resolution fMRI is currently the method of choice. Further-
more, the cognitive tests chosen had the highest sensitivity
to detect cognitive changes. However, these tests may not
be sufﬁciently sensitive to detect very subtle changes in
type 1 diabetes–associated cognitive decline. Second, age
of disease onset and subsequently disease duration differ
between the patient groups. Although the percentages of
early disease onset do not statistically differ between
groups, for the type 1 diabetes
 patients age of onset
reﬂects childhood and early adolescence, whereas for the
type 1 diabetes
 patients it reﬂects late adolescence and
early adulthood. In a subsequent analysis we compared
both patient groups, additionally correcting for age of
diabetes onset and diabetes duration (see supplementary
Table 3A–C, available in an online appendix). Taking into
account the risk of emerging power problems when adding
two more covariates to this small sample, these adjust-
ments did not essentially change the conclusions regard-
ing cognitive functioning and functional connectivity.
Disease duration might be less of a confounder here as the
type 1 diabetes
 patients had an average disease duration
of almost 20 years, which is sufﬁcient for complications to
develop. As stated before, an increase in functional con-
nectivity was found for the lower  band in type 1
diabetes
 patients. Although the possibility of a statistical
aberration cannot be completely ruled out, synchroniza-
tion likelihood tended to be higher for 20 of the 23
anatomical locations of the lower  band in type 1
diabetes
 patients than control subjects (supplementary
Table 4, available in an online appendix). Moreover, we
additionally repeated the post hoc MANCOVA for the
lower  band correcting for multiple comparisons. This
did not change the statistical signiﬁcance of the parietooc-
cipital pathway. Thus, these ﬁndings suggest that the
signiﬁcant increase detected is valid. As both age and
depressive symptoms differed between groups, we statis-
tically corrected for both variables in all analyses. Supple-
mentary Table 5, available in an online appendix,
summarizes the relation between age and depressive
symptoms and cognitive and MEG variables. Third, A1C
values over the time period preceding MEG recording and
neuropsychological assessment unfortunately were not
available.
In conclusion, this study showed that changes in func-
tional brain connectivity and cognitive function exist in
type 1 diabetic patients with and without microvascular
complications. Furthermore, interactions between func-
tional connectivity and cognitive domains have been dem-
onstrated. Whether these abnormalities have clinical
implications remains to be determined. Longitudinal re-
search in larger samples is required to determine the
predictive clinical value of our ﬁndings for the progression
of cognitive deterioration in type 1 diabetic patients as
well as its potential to serve as clinical outcome
parameter.
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